These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 2733704

  • 1. Bereitschaftspotential in tardive dyskinesia.
    Adler LE, Pecevich M, Nagamoto H.
    Mov Disord; 1989; 4(2):105-12. PubMed ID: 2733704
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The P 300 potential in schizophrenia].
    Laurent A, Garcia-Larrea L, Dalery J, Terra JL, D'Amato T, Marie-Cardine M, Mauguière F.
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [Abstract] [Full Text] [Related]

  • 4. An electroencephalographic study of psychiatric inpatients with antipsychotic-induced tardive dyskinesia.
    Koshino Y, Hiramatsu H, Isaki K, Yamaguchi N.
    Clin Electroencephalogr; 1986 Jan; 17(1):30-5. PubMed ID: 2869843
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
    Ganzini L, Casey DE, Hoffman WF, McCall AL.
    Arch Intern Med; 1993 Jun 28; 153(12):1469-75. PubMed ID: 8512437
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dissociation between motor potential and contingent negative variation after lesions of some basal ganglia in man: electrophysiological study of torticollis.
    Podivínský F.
    Act Nerv Super (Praha); 1978 Dec 28; 20(4):312-8. PubMed ID: 735745
    [Abstract] [Full Text] [Related]

  • 8. Cortical slow potential shifts in tardive dyskinesia.
    Knott VJ, Radonjic D, Lapierre YD.
    Prog Neuropsychopharmacol Biol Psychiatry; 1982 Dec 28; 6(4-6):499-502. PubMed ID: 6131487
    [Abstract] [Full Text] [Related]

  • 9. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM, Yu SC, Lin CC.
    J Clin Psychiatry; 2003 Nov 28; 64(11):1342-8. PubMed ID: 14658949
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE.
    J Clin Psychiatry; 2000 Nov 28; 61 Suppl 4():5-9. PubMed ID: 10739324
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bereitschaftspotential preceding voluntary saccades is abnormal in patients with Parkinson's disease.
    Shimizu N, Okiyama R.
    Adv Neurol; 1993 Nov 28; 60():398-402. PubMed ID: 8420161
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA, Mythily, Lum A, Huak CY, Kane J.
    Hum Psychopharmacol; 2002 Aug 28; 17(6):305-7. PubMed ID: 12404676
    [Abstract] [Full Text] [Related]

  • 19. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA, Andersson M, Andersson KE, Cenci MA.
    Neurobiol Dis; 2001 Apr 28; 8(2):220-39. PubMed ID: 11300719
    [Abstract] [Full Text] [Related]

  • 20. Pathophysiologic basis of tardive dyskinesia.
    Baldessarini RJ, Tarsy D.
    Adv Biochem Psychopharmacol; 1980 Apr 28; 24():451-5. PubMed ID: 6105793
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.